| Oct 30 |
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
|
| Oct 21 |
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
|
| Oct 1 |
PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
|
| Sep 3 |
PolyPid to Participate in Three Upcoming Fall Investor Conferences
|
| Aug 30 |
PolyPid files to sell 3.91M ordinary shares for holders
|
| Aug 14 |
PolyPid Ltd (PYPD) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
PolyPid GAAP EPS of -$1.25
|
| Aug 14 |
PolyPid Provides Corporate Update and Reports Second Quarter 2024 Financial Results
|
| Aug 2 |
PolyPid Announces Private Placement for Up to $14 Million in Gross Proceeds
|
| Jul 31 |
PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024
|
